Investigating how microcircuit abnormalities modulate brain-wide network dynamics to cause seizures across variant SCN1A mutations, using a zebrafish
Investigating how microcircuit abnormalities modulate brain-wide network dynamics to cause seizures across variant SCN1A mutations, using a zebrafish
批准号:
1982291
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
本研究的目的是研究SCN1A功能缺失突变(编码电压门控钠通道)如何导致异常网络动力学导致癫痫发作,如在Dravet综合征患者中报道的那样。问题1 (Q1):钠通道功能缺失突变如何导致神经元兴奋的矛盾增加?假设1:该突变优先导致抑制性神经元兴奋性降低,导致兴奋性神经元异常去抑制。问题2 (Q2):不同的SCN1A突变如何导致患者不同的生物物理异常,从而导致共同的临床表型?假设2:SCN1A基因不同区域的突变不同程度地改变了钠通道的门控动力学,这些门控动力学向下游收敛,导致网络的超兴奋性。问题3 (Q3):通过光片荧光显微镜(LSFM)和脑电图(EEG)测量,SCN1A突变如何导致异常的网络动力学?假设3:SCN1A突变导致LSFM和EEG中常见的神经元偶联异常。
英文摘要
The aim of this investigation is to examine how SCN1A loss-of-function mutations (encoding a voltage-gated sodium channel) lead to abnormal network dynamics resulting in epileptic seizures, as reported in patients with Dravet syndrome. Question 1 (Q1): How does a loss-of-function sodium channel mutation lead to a paradoxical increase in neuronal excitation?Hypothesis 1: The mutation preferentially leads to decreased excitability of inhibitory neurons causing aberrant disinhibition of excitatory neurons. Question 2 (Q2): How do different SCN1A mutations, causing divergent biophysical abnormalities in patients, lead to a common clinical phenotype?Hypothesis 2: Mutations along different regions of the SCN1A gene differentially alter sodium channel gating dynamics, which downstream converge to cause network hyper-excitability. Question 3 (Q3): How do SCN1A mutations lead to abnormal network dynamics, as measured with light sheet fluorescence microscopy (LSFM) and electro-encephalogram (EEG)?Hypothesis 3: SCN1A mutations result in common abnormalities in neuronal coupling across LSFM and EEG.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
The effects of antipsychotics on cingulate morphology and synaptic density in psychosis: A translational approach
抗精神病药物对精神病中扣带皮层形态和突触密度的影响:一种转化方法
DOI:
10.1016/j.euroneuro.2018.11.602
发表时间:
2019
期刊:
European Neuropsychopharmacology
影响因子:
5.6
作者:
[Burrows D]
通讯作者:
Burrows D
海外基金